Skip to content

Technical verification scheme of treatment of mild to moderate knee osteoarthritis with fire acupuncture

Technical verification scheme of treatment of mild to moderate knee osteoarthritis with fire acupuncture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019162
Enrollment
Unknown
Registered
2018-10-29
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Group 1:Fire needle+Basic health management
Group 2:Ordinary acupuncture + basic treatment

Sponsors

Beijing Huairou District Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Aged 38 to 85 years; (2) Meet the diagnostic criteria for primary knee osteoarthritis; (3) Patients with mild to moderate knee osteoarthritis (Kellgren-lawrence scoring standard 1-2); (4) Able to receive fire acupuncture treatment; (5) Voluntary participation in the study and signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) Secondary knee osteoarthritis; (2) The knee joint has a history of trauma or surgery in the past year, severe joint deformity (varus or valgus= 8 degree); (3) Injection of glucocorticoid or sodium hyaluronate into the articular cavity of the target knee within 3 months or 2 weeks or receive acupuncture or moxibustion for symptomatic hip arthritis or patellar arthritis on the same side of the target knee joint within 2 weeks; (4) Symptomatic hip or patellar arthritis on the same side of the target knee joint; (5) Inflammatory or other rheumatic diseases; (6)Acute knee meniscus injury, or acute knee injury/fracture around the knee, tumor around the knee, tuberculosis or idiopathic osteonecrosis; (7) Patients taking paracetamol non-steroidal anti-inflammatory drugs or analgesics for other diseases; (8) Uncontrolled hypertension or diabetes, severe cardiovascular, pulmonary, liver, spleen, kidney and hematopoietic diseases, tumor hemorrhage and mental illness; (9) scar diathesis or skin sensory impairment; (10) Pregnant or lactating woman.

Design outcomes

Primary

MeasureTime frame
WOMAC;Proportion of clinical improvement;

Secondary

MeasureTime frame
WOMAC;Proportion of clinical improvement;

Countries

China

Contacts

Public ContactFu Yuanbo

Beijing Huairou District Hospital of Traditional Chinese Medicine

fybsir@126.com+86 18701468963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026